Adherence to antiretroviral therapy among HIV-infected prison inmates (Spain)

Soto Blanco JM; Ruiz Pérez I; March JC
February 2005
International Journal of STD & AIDS;Feb2005, Vol. 16 Issue 2, p133
Academic Journal
Journal Article
This cross-sectional study was carried out in two Spanish prisons. A group of 177 HIV-infected prison inmates were interviewed. Standardized personal interviews using a structured questionnaire were conducted to assess socio-demographic features and prison setting characteristics, clinical variables, social support and drug consumption. A simplified four-item questionnaire for self-reported adherence was used. A total of 24.3% were non-adherent. Predictors of non-adherence in the multivariate analysis included poor or lack of ability to follow the prescribed treatment regimen, no visits in a month, anxious and/or depressed mood, difficulty in taking medication, receiving methadone treatment, cannabis consumption and robbery as the reason for imprisonment. Adherence to antiretroviral therapy was higher than in the wider community. However, other variables related to the correctional setting, such as assignments within the facility, adaptability of the prison system to authorize the cell being opened in the event of missed medication, or legal situation had no effect on adherence for inmates with HIV disease.


Related Articles

  • Adherence to Directly Observed Antiretroviral Therapy among Human Immunodeficiency Virus--Infected Prison Inmates. Wohl, David A.; Stephenson, Becky L.; Golin, Carol E.; Kiziah, C. Nichole; Rosen, David; Ngo, Bich; Honghu Liu; Kaplan, Andrew H. // Clinical Infectious Diseases;6/15/2003, Vol. 36 Issue 12, p1572 

    Directly observed therapy (DOT) for human immunodeficiency virus (HIV) infection is commonly used in correctional settings; however, the efficacy of DOT for treating HIV infection has not been determined. We prospectively assessed adherence to antiretroviral therapy regimens among 31...

  • A Pilot Study of Health Beliefs and Attitudes Concerning Measures of Antiretroviral Adherence Among Prisoners Receiving Directly Observed Antiretroviral Therapy. White, Becky L.; Wohl, David A.; Hays, Ron D.; Golin, Carol E.; Liu, Honghu; Kiziah, C. Nichole; Simpson, Gregory; Kaplan, Andrew H. // AIDS Patient Care & STDs;Jun2006, Vol. 20 Issue 6, p408 

    High level adherence to antiretroviral therapy (ART) is required to achieve and maintain suppression of HIV replication. Although directly observed therapy (DOT) has been suggested as an intervention to improve adherence, there is a paucity of data describing the attitudes and beliefs regarding...

  • Enrollment in Outpatient Care Among Newly Released Prison Inmates with HIV Infection. Baillargeon, Jacques G.; Giordano, Thomas P.; Hazke, Amy Jo; Baillargeon, Gwen; Rich, Josiah D.; Paar, David P. // Public Health Reports;Jan/Feb2010 Supplement, Vol. 125, p64 

    Objectives. Although many prisoners infected with human immunodeficiency virus (HIV) initiate and adhere to treatment regimens while incarcerated, the benefits of in-prison therapy are frequently lost after community reentry. Little information is available on the percentage of released inmates...

  • Most HIV-infected inmates are eligible for ART.  // AIDS Alert;Jul2009, Vol. 24 Issue 7, p75 

    The article reports on the need for HIV-infected inmates to have access on antiretroviral therapy (ART) in the U.S.

  • Prevalence of HIV-1 drug resistance mutations among Spanish prison inmates. García-Guerrero, J.; de la Hoya, P. Sáiz; Portilla, J.; Marco, A.; Sánchez-Payá, J.; Moreno, S. // European Journal of Clinical Microbiology & Infectious Diseases;Nov2006, Vol. 25 Issue 11, p695 

    The aim of this cross-sectional study was to analyse the prevalence of HIV-1 drug-resistance mutations among HIV-1-infected prison inmates in Spain. Treatment-naive and treatment-experienced patients with an HIV RNA viral load of ≥2,000 copies/ml were included. To ensure that the study...

  • Quantitative and qualitative correlates of cervicovaginal herpes simplex virus type 2 shedding among HIV-infected women in the Women's Interagency HIV Study. Aumakhan, B.; Gange, S. J.; Beyrer, C.; Gaydos, C. A.; Minkoff, H.; Merenstein, D. J.; Cohen, M. H.; Anastos, K.; Greenblatt, R.; Nowicki, M. J.; Quinn, T. C. // International Journal of STD & AIDS;May2011, Vol. 22 Issue 5, p273 

    We identified demographic, clinical and biological determinants of herpes simplex virus type 2 (HSV-2) shedding among HIV-infected participants in the Women's HIV Interagency Study (WIHS). Cervicovaginal lavage (CVL) specimens from 369 HIV-infected HSV seropositive women were tested with TaqMan...

  • Considerations for Antiretroviral Therapy Among HIV-Infected Pregnant Women.  // MMWR: Morbidity & Mortality Weekly Report;5/17/2002 Supplement RR-7, Vol. 51 Issue 19, p22 

    Addresses the considerations for antiretroviral therapy among HIV-infected pregnant women. Basis of the antiretroviral treatment recommendations for HIV-infected pregnant women; Benefit of using antiretroviral prophylaxis; Effect of temporary discontinuation of antiretroviral therapy.

  • Adherence to Highly Active Antiretroviral Therapy in HIV-Infected Inmates. Inés, Sandra M.; Moralejo, Leticia; Marcos, Miguel; Fuertes, Aurelio; Luna, Guillermo // Current HIV Research;Mar2008, Vol. 6 Issue 2, p164 

    Adherence to highly active antiretroviral therapy (HAART) has been scarcely studied in correctional settings. Our study aims to evaluate the relationship between adherence and virological outcome and to determine factors related to adherence in correctional settings. A cross-sectional...

  • Limited Spending: An Analysis of Correctional Expenditures on Antiretrovirals for HIV-Infected Prisoners. Zaller, Nick; Thurmond, Portia; Rich, Josiah D. // Public Health Reports;Jan/Feb2007, Vol. 122 Issue 1, p49 

    Objective. Correctional facilities provide a critical opportunity to treat and manage human immunodeficiency virus (HIV) and HIV-related complications among inmates. Inmates bear a higher HIV burden than the general population, and many have never received HIV care prior to incarceration. The...

  • HIV behind Bars: Human Immunodeficiency Virus Cluster Analysis and Drug Resistance in a Reference Correctional Unit from Southern Brazil. Prellwitz, Isabel M.; Alves, Brunna M.; Ikeda, Maria Letícia R.; Kuhleis, Daniele; Picon, Pedro D.; Jarczewski, Carla A.; Osório, Marta R.; Sánchez, Alexandra; Seuánez, Héctor N.; Larouzé, Bernard; Soares, Marcelo A.; Soares, Esmeralda A. // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    People deprived of liberty in prisons are at higher risk of infection by the human immunodeficiency virus (HIV) due to their increased exposure through intravenous drug use, unprotected sexual activity, tattooing in prison and blood exposure in fights and rebellions. Yet, the contribution of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics